These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4428162)

  • 21. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 23. [Triella: a French multicenter double blind clinical study].
    Castaigne JP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of oral contraceptives on the variations in serum-iron during the menstrual cycle.
    Mardell M; Zilva JF
    Lancet; 1967 Dec; 2(7530):1323-5. PubMed ID: 4170025
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for a triphasic oral contraceptive.
    Pasquale SA
    J Reprod Med; 1984 Jul; 29(7 Suppl):560-7. PubMed ID: 6481710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The acute effects of exercise on prolactin and growth hormone secretion: comparison between sedentary women and women runners with normal and abnormal menstrual cycles.
    Chang FE; Dodds WG; Sullivan M; Kim MH; Malarkey WB
    J Clin Endocrinol Metab; 1986 Mar; 62(3):551-6. PubMed ID: 3080465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the sebaceous secretions of the skin of the forehead under the treatment with three oral contraceptives. Diane, Neogynon and Lyndiol (author's transl)].
    Leis D; Clarin A
    Geburtshilfe Frauenheilkd; 1979 Jan; 39(1):54-7. PubMed ID: 422029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol and exercise as a screening test for growth hormone deficiency.
    Shanis BS; Moshang T
    Pediatrics; 1976 May; 57(5):712-4. PubMed ID: 940711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Suppression of the endocrine activity of the ovaries].
    Jayle MF
    Rev Fr Endocrinol Clin; 1967; 8(5):407-15. PubMed ID: 4230393
    [No Abstract]   [Full Text] [Related]  

  • 32. Electroencephalographic changes in women treated with contraceptive steroids.
    Gautray JP; Eberhard A; Jalivet A; Leygonie G
    Basic Life Sci; 1974; 4(PART A):385-97. PubMed ID: 4447577
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
    Martin JG; Buono MJ
    Clin Physiol; 1997 Jul; 17(4):401-8. PubMed ID: 19361151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of oral contraceptives on hormone profiles of oligomenorrheic adolescent cycles.
    Siegberg R; Nilsson CG; Stenman UH; Widholm O
    Contraception; 1987 Jan; 35(1):29-40. PubMed ID: 3568657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of oral contraceptives on plasma renin activity and plasma renin substrate concentration (author's transl)].
    Kaulhausen H; Oehm W; Fritzsche G; Breuer H
    Z Klin Chem Klin Biochem; 1974 Sep; 12(9):408-14. PubMed ID: 4372825
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of exercise duration and mode on the growth hormone responses in young women on oral contraceptives.
    Sauro LM; Kanaley JA
    Eur J Appl Physiol; 2003 Sep; 90(1-2):69-75. PubMed ID: 12811570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects of oral contraceptives during exercise.
    Lehtovirta P; Kuikka J; Pyörälä T
    Int J Gynaecol Obstet; 1977; 15(1):35-7. PubMed ID: 923890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma ascorbic acid concentrations and oral contraceptives.
    Rivers JM; Devine MM
    Am J Clin Nutr; 1972 Jul; 25(7):684-9. PubMed ID: 5035056
    [No Abstract]   [Full Text] [Related]  

  • 39. The menstrual cycle after withdrawal of oral contraceptives with particular reference to return of ovulation.
    Jordan K
    Mater Med Pol; 1975; 7(2):126-32. PubMed ID: 1142823
    [No Abstract]   [Full Text] [Related]  

  • 40. Thyroid function tests during pregnancy, the normal menstrual cycle and in women using oral contraceptives.
    Standeven RM
    J Endocrinol; 1969 Feb; 43(2):217-24. PubMed ID: 4180278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.